RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the
laboratory may help doctors identify biomarkers related to cancer. Riluzole may help slow the
growth of tumor cells.
PURPOSE: This phase I trial is studying riluzole in women with stage I, stage II, or stage
IIIA breast cancer.